Hangzhou Tian-Mu-Shan Pharmaceutical Enterprise Co.,Ltd. Posted 23.6 Million Yuan Net Loss in First Half of 2023

Hangzhou Tian-Mu-Shan Pharmaceutical Enterprise Co.,Ltd. (杭州天目山药业股份有限公司) (600671.SH) reported a net loss of 23.6 million yuan in the first half of 2023, narrowing 3% year-on-year.

Meanwhile, the company posted 51 million yuan in revenue, down 1.8% year-on-year.

At the end of the reporting period, it had 256.6 million yuan in total assets and 275.8 million yuan in total liabilities, with a liability-to-asset ratio of 107.5%.